$0.90
Today
as of Jul 22, 16:40 ET
Last 30 days
Recent Press Releases & News
VYNE Approves 1-for-50 Reverse Stock Split
VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger with Yarrow Bioscience
VYNE Therapeutics Declares Estimated $0.38-Per-Share Special Cash Dividend Ahead of Yarrow Merger
Overview
52-week range
$0.28
$1.96
37% of range
Avg surprise (last 2)
+37.3%
Avg reaction (last 2)
-2.6%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Fri May 15, 2026 | Mar/2026 | $-0.08 | — | — | +60.0% | 0.0% | earnings |
| Thu Aug 14, 2025 | Jun/2025 | $-0.13 | $-0.23 | +43.5% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.20 | $-0.29 | +31.0% | — | -5.1% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.29 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.22 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.15 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-2.01 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-3.09 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-1.74 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 13, 2026 | Jun/2026 | OTHER | — | -$0.13 |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-4M | — | $-8M | $-9M | — | $-13M | $-10M | $-7M |
| Net income | $-4M | — | $-6M | $-9M | — | $-12M | $-9M | $-6M |
| EPS (diluted) | $-0.08 | — | $-0.13 | $-0.20 | — | $-0.29 | $-0.22 | $-0.15 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $25M | $24M | $22M | $28M | $20M | $16M | $30M | $19M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $26M | $30M | $44M | $55M | $64M | $74M | $84M | $90M |
| Total assets | $26M | $30M | $45M | $56M | $67M | $76M | $87M | $92M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $1M | $2M | $6M | $12M | $15M | $13M | $12M | $8M |
| Total equity | $25M | $28M | $39M | $44M | $52M | $64M | $75M | $83M |
Implied volatility — last 90 days
No IV snapshots yet for VYNE.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.